Загрузка...
Benefits of Renin-Angiotensin Blockade on Retinopathy in Type 1 Diabetes Vary With Glycemic Control
OBJECTIVE: Optimal glycemic control slows diabetic retinopathy (DR) development and progression and is the standard of care for type 1 diabetes. However, these glycemic goals are difficult to achieve and sustain in clinical practice. The Renin Angiotensin System Study (RASS) showed that renin-angiot...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Diabetes Association
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3142059/ https://ncbi.nlm.nih.gov/pubmed/21715517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc11-0476 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|